Drugs / Anti-CLL1 CART cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04923919 | Sep 2021 → Dec 2024 | acute myeloid leukemia | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-CLL1 CART cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04923919 ↗ |
| Modality | Cell therapy | “autologous CAR T cells” NCT04923919 ↗ |
| Route | Intravenous | “single, intravenous infusion” NCT04923919 ↗ |